BARRIER PERCEPTION FACTORS AFFECTING THE ACCEPTANCE OF THE COVID-19 VACCINE IN SALATIGA CITY
Hubungan Faktor Penghambat Vaksinasi dengan Penerimaan Vaksin COVID-19 di Kota Salatiga
Downloads
Background: In Salatiga City, COVID-19 immunization still needs to meet the 70% vaccination target needed to generate herd immunity. Vaccine skepticism and injection phobia can be barriers. A study of community barriers to COVID-19 vaccination and vaccine uptake is needed. Purpose: This study aimed to analyze barriers affecting the acceptance of the COVID-19 vaccine in Salatiga City. Methods: The study collected data from 323 Salatiga City people. Fear of pain, doubts about the COVID-19 vaccine, perception of fear of AEFI (Adverse Events Following Immunization), perception of accessibility of the COVID-19 vaccine, and the perception of information about the COVID-19 vaccine were independent variables in this study. Acceptance of COVID-19 vaccination is dependent. Data analysis using Chi-Square with 0.05 significance. Results: The results of this study found a relationship between fear of pain (p-value = 0.00), doubt about the COVID-19 vaccine (p-value = 0.00), perception of fear of AEFI (p-value = 0.00), perception of accessibility of COVID-19 vaccine (p-value = 0.00), and perception of information about COVID-19 vaccine (p-value = 0.00) and acceptance of the COVID-19 vaccine by Salatiga City residents. Conclusion: Perceived COVID-19 vaccination barriers affected vaccine acceptance. Acceptance of COVID-19 vaccination in Salatiga City is related to fear of pain, doubt about the COVID-19 vaccine, perception of fear of AEFI, perception of accessibility of the COVID-19 vaccine, and perception of information about the COVID-19 vaccine. Salatiga City's COVID-19 education efforts should focus on vaccine safety and side effects in collaboration with health cadres and cross-sector collaboration.
Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci Total Environ. 2020;730:138996.
KPC-PEN. Data sebaran kasus COVID-19 dan capaian vaksinasi COVID-19. Covid19.go.id. 2021.
Dinkes Kota Salatiga. Update informasi COVID-19 Kota Salatiga 16 Juli 2021. Humas Setda Kota Salatiga. 2021.
Permenkes RI. Pelaksanaan vaksinasi dalam rangka penanggulangan pandemi Corona Virus Disease 2019 (COVID-19). Jakarta; 2020 p. 1–22.
Kemenkes RI, ITAGI, WHO, UNICEF. Survei penerimaan vaksin COVID-19 di Indonesia. Jakarta; 2020.
Bartsch SM, O'Shea KJ, Ferguson MC, Bottazzi ME, Wedlock PT, Strych U, et al. Vaccine efficacy needed for a COVID-19 Coronavirus Vaccine to prevent or stop an epidemic as the sole intervention. Am J Prev Med. 2020;59(4):493–503.
Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Heal Educ Behav. 1988;15(2):175–83.
Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020;8(482):1–14.
Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12(1):1–15.
Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 Vaccine Demand and Hesitancy: A Nationwide Online Survey in China. PLOS Neglected Trop Dis. 2020;14(12).
Ward JK, Alleaume C, Peretti-watel P. Social Science & Medicine The French public's attitudes to a future COVID-19 vaccine : The politicization of a public health issue. Soc Sci Med. 2020;265(113414).
Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States : How many people would get vaccinated ? Vaccine. 2021;38(42):6500–7.
Tran VD, Pak T V., Gribkova EI, Galkina GA, Loskutova EE, Dorofeeva V V., et al. Determinants of COVID-19 Vaccine Acceptance in a High Infection-rate Country: A Cross-sectional Study in Russia. Pharm Pract (Granada). 2021;19(1):1–9.
Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Heal Econ. 2020;21(7):977–82.
Ali M, Hossain A. What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey. BMJ Open. 2021;11(8).
Borriello A, Master D, Pellegrini A, Rose JM. Preferences for a COVID-19 vaccine in Australia. Vaccine. 2021;39(3):473–9.
Hossain MB, Alam MZ, Islam MS, Sultan S, Faysal MM, Rima S, et al. COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey. PLoS One. 2021;16(12):e0260821.
Chu H, Liu S. Integrating health behavior theories to predict American's intention to receive a COVID-19 vaccine. Patient Educ Couns. 2021;S0738-3991(21):00129–4.
Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021;39(7):1148–56.
Raja AS, Niforatos JD, Anaya N, Graterol J, Rodriguez RM. Vaccine hesitancy and reasons for refusing the COVID-19 vaccination among the U.S. public: A cross-sectional survey. medRxiv. 2021;
Zhao Y-M, Liu L, Sun J, Yan W, Yuan K, Zheng Y-B, et al. Public Willingness and Determinants of COVID-19 Vaccination at the Initial Stage of Mass Vaccination in China. Vaccines. 2021;9(10):1172.
Goruntla N, Chintamani SH, P B, S S, Veerabhadrappa KV, Bhupalam P, et al. Predictors of acceptance and willingness to pay for the COVID-19 vaccine in the general public of India: A health belief model approach. Asian Pac J Trop Med. 2021;14(4):165–75.
Dwipayana IDAP, Sutarini IDAAD. COVID-19 vaccination options for immunosuppressed cancer patients. J Berk Epidemiol. 2021 Jan 29;9(1).
Shekhar R, Sheikh AB, Upadhyay S, Singh M, Kottewar S, Mir H, et al. COVID-19 Vaccine acceptance among health care workers in the United States. Vaccines. 2021;9(2):119.
Callaghan T, Moghtaderi A, Lueck JA, Hotez P, Strych U, Dor A, et al. Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med. 2021;272(113638).
Crawshaw AF, Deal A, Rustage K, Forster AS, Campos-Matos I, Vandrevala T, et al. What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants? J Travel Med. 2021;28(4):1–4.
Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Heal. 2021;6(4):e210–21.
Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H. Willingness to Pay and Financing Preferences for COVID-19 Vaccination in China. Vaccine. 2020;39(14):1968–76.
Robertson E, Reeve KS, Niedzwiedz CL, Moore J, Blake M, Green M, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021;94:41–50.
Herdyana E, Husnunisa W. Perbedaan minat ibu hamil trimester III dalam menggunakan AKDR pasca plasenta sebelum dan sesudah penyuluhan. J Kebidanan Dharma Husada. 2017;6(2):147–52.
- Every manuscript submitted to must observe the policy and terms set by the Jurnal Berkala Epidemiologi
- Publication rights to manuscript content published by the Jurnal Berkala Epidemiologi is owned by the journal with the consent and approval of the author(s) concerned. (download copyright agreement)
- Complete texts of electronically published manuscripts can be accessed free of charge if used for educational and research purposes according to copyright regulations.
JBE by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
